Why Do SGLT2 Inhibitors Inhibit Only 30–50% of Renal Glucose Reabsorption in Humans?

(Downloading may take up to 30 seconds. If the slide opens in your browser, select File -> Save As to save it.)

Click on image to view larger version.

FIG. 1.
FIG. 1.

SGLT2 inhibitors in late-stage clinical trials.

This Article

  1. Diabetes vol. 61 no. 9 2199-2204